Home Medicine Prenatal findings, neonatal symptoms and neurodevelopmental outcome of congenital cytomegalovirus infection in a university hospital in Montreal, Quebec
Article
Licensed
Unlicensed Requires Authentication

Prenatal findings, neonatal symptoms and neurodevelopmental outcome of congenital cytomegalovirus infection in a university hospital in Montreal, Quebec

  • ORCID logo , , , , , , and EMAIL logo
Published/Copyright: February 6, 2020

Abstract

Background

Outcome of congenital cytomegalovirus (cCMV) infection in the absence of routine CMV screening and third-trimester scan in North America is scarcely documented. The aim of this study was to assess the severe outcomes related to cCMV according to the indication for screening.

Methods

This was a retrospective study of 84 mother-child pairs followed for cCMV between 2003 and 2017 at CHU Sainte-Justine in Montreal, Canada. Prenatal ultrasound, neonatal symptoms, neuroimaging and severe outcomes (cerebral palsy, severe cognitive impairment, bilateral hearing loss or neonatal death) were reviewed.

Results

Among 38 cases with abnormal prenatal ultrasound, 41.9% of live-born infants developed severe outcomes. Sixteen (42.1%) were detected in the third trimester. Among 16 cases diagnosed prenatally because of maternal history, all had normal prenatal ultrasound, and none developed severe outcomes. Among cases diagnosed postnatally because of neonatal symptoms, 25% developed severe outcomes. All infants who developed severe outcomes had moderate/severe neonatal symptoms.

Conclusion

Outcome of cCMV infection varies according to the reason for screening and timing of diagnosis. Any prenatal ultrasound anomaly might indicate a risk of severe outcome, and warrants a detailed ultrasound scan. However, late detection, or postnatal diagnosis, represented more than half of the cases, and awareness of this will help ensuring optimal management.


Corresponding author: Dr. Isabelle Boucoiran, MD, MSc, Women and Children Infectious Diseases Center, CHU Sainte-Justine, 3175 Côte Sainte-Catherine, Montreal, H3T 1C5, QC, Canada; and Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology and of Social and Preventive Medicine, Université de Montréal, Montreal, QC, Canada, Tel.: +1 514 345-4931 #4909, Fax: +1 514 345-4878

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Funder Name: Fonds de Recherche du Québec – Santé, Funder Id: http://dx.doi.org/10.13039/501100000156, Awarded to Fatima Kakkar and Isabelle Boucoiran.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010;20:202–13.10.1002/rmv.655Search in Google Scholar

2. Colugnati FA, Staras SA, Dollard SC, Cannon MJ. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007;7:71.10.1186/1471-2334-7-71Search in Google Scholar

3. Lamarre V, Gilbert NL, Rousseau C, Gyorkos TW, Fraser WD. Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Quebec, 2010–2013. Epidemiol Infect 2016;144:1701–9.10.1017/S0950268815003167Search in Google Scholar

4. Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis 2017;17:e177–88.10.1016/S1473-3099(17)30143-3Search in Google Scholar

5. Yinon Y, Farine D, Yudin MH. No. 240-Cytomegalovirus infection in pregnancy. J Obstet Gynaecol Can 2018;40:e134–41.10.1016/j.jogc.2017.11.018Search in Google Scholar PubMed

6. Society for Maternal-Fetal Medicine, Hughes BL, Gyamfi-Bannerman C. Diagnosis and antenatal management of congenital cytomegalovirus infection. Am J Obstet Gynecol 2016;214:B5–11.10.1016/j.ajog.2016.02.042Search in Google Scholar PubMed

7. Vaudry W, Lee BE, Rosychuk RJ. Congenital cytomegalovirus infection in Canada: active surveillance for cases diagnosed by paediatricians. Paediatr Child Health 2014;19:e1–5.Search in Google Scholar

8. Leruez-Ville M, Stirnemann J, Sellier Y, Guilleminot T, Dejean A, Magny JF, et al. Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis. Am J Obstet Gynecol 2016;215:342.e1–9.10.1016/j.ajog.2016.03.052Search in Google Scholar PubMed

9. Leyder M, Vorsselmans A, Done E, Van Berkel K, Faron G, Foulon I, et al. Primary maternal cytomegalovirus infections: accuracy of fetal ultrasound for predicting sequelae in offspring. Am J Obstet Gynecol 2016;215:638.e1–8.10.1016/j.ajog.2016.06.003Search in Google Scholar PubMed

10. Guerra B, Simonazzi G, Puccetti C, Lanari M, Farina A, Lazzarotto T, et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008;198:380.e1–7.10.1016/j.ajog.2007.09.052Search in Google Scholar PubMed

11. Faure-Bardon V, Magny JF, Parodi M, Couderc S, Garcia P, Maillotte AM, et al. Sequelae of congenital cytomegalovirus (cCMV) following maternal primary infection are limited to those acquired in the first trimester of pregnancy. Clin Infect Dis 2019;69:1526–32.10.1093/cid/ciy1128Search in Google Scholar PubMed

12. Lausman A, Kingdom J, Maternal Fetal Medicine Committee. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can 2013;35:741–8.10.1016/S1701-2163(15)30865-3Search in Google Scholar

13. Kakkar F, Boucoiran I. The Women and Children’s Infectious Diseases Center: an integrated approach to congenital infectious diseases. Clin Invest Med 2019;41:E211–2.10.25011/cim.v41i4.32223Search in Google Scholar PubMed

14. Delforge ML, Costa E, Brancart F, Goldman D, Montesinos I, Zaytouni S, et al. Presence of Cytomegalovirus in urine and blood of pregnant women with primary infection might be associated with fetal infection. J Clin Virol 2017;90:14–7.10.1016/j.jcv.2017.03.004Search in Google Scholar PubMed

15. Enders G, Daiminger A, Bader U, Exler S, Enders M. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 2011;52:244–6.10.1016/j.jcv.2011.07.005Search in Google Scholar PubMed

16. Nigro G, Adler SP, La Torre R, Best AM, Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350–62.10.1056/NEJMoa043337Search in Google Scholar PubMed

17. Gunkel J, Nijman J, Verboon-Maciolek MA, Wolfs T, de Vries LS. International opinions and national surveillance suggest insufficient consensus regarding the recognition and management practices of infants with congenital cytomegalovirus infections. Acta Paediatr 2017;106:1493–8.10.1111/apa.13882Search in Google Scholar PubMed

18. Grandjean Lapierre S, Vallieres E, Rabaamad L, Labrecque M, Chartrand C, Renaud C. Evaluation of the Abbott ARCHITECT cytomegalovirus IgM/IgG, rubella IgM/IgG, and syphilis treponemal antibodies enzyme immunoassays in a mother and child health center population. Diagn Microbiol Infect Dis 2019;94:231–5.10.1016/j.diagmicrobio.2018.12.017Search in Google Scholar PubMed

19. Minsart A, Smiljkovic M, Renaud C, Gagné M, Lamarre V, Kakkar F, et al. Use of cytomegalovirus-specific hyperimmunoglobulins in pregnancy: a retrospective cohort. J Obstet Gynaecol Can 2018;40:1409–16.10.1016/j.jogc.2018.03.013Search in Google Scholar PubMed

20. Luck SE, Wieringa JW, Blazquez-Gamero D, Henneke P, Schuster K, Butler K, et al. Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management. Pediatr Infect Dis J 2017;36:1205–13.10.1097/INF.0000000000001763Search in Google Scholar PubMed

21. Smiljkovic M, Renaud C, Tapiero B, Lamarre V, Kakkar F. Head ultrasound, CT or MRI? The choice of neuroimaging in the assessment of infants with congenital cytomegalovirus infection. BMC Pediatr 2019;19:180.10.1186/s12887-019-1562-zSearch in Google Scholar PubMed PubMed Central

22. Giannattasio A, Di Costanzo P, De Matteis A, Milite P, De Martino D, Bucci L, et al. Outcomes of congenital cytomegalovirus disease following maternal primary and non-primary infection. J Clin Virol 2017;96:32–6.10.1016/j.jcv.2017.09.006Search in Google Scholar PubMed

23. Ancora G, Lanari M, Lazzarotto T, Venturi V, Tridapalli E, Sandri F, et al. Cranial ultrasound scanning and prediction of outcome in newborns with congenital cytomegalovirus infection. J Pediatr 2007;150:157–61.10.1016/j.jpeds.2006.11.032Search in Google Scholar PubMed

24. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214–23.10.1111/j.1469-8749.1997.tb07414.xSearch in Google Scholar PubMed

25. de Kleijn JL, van Kalmthout LWM, van der Vossen MJB, Vonck BMD, Topsakal V, Bruijnzeel H. Identification of pure-tone audiologic thresholds for pediatric cochlear implant candidacy: a systematic review. JAMA Otolaryngol Head Neck Surg 2018;144:630–8.10.1001/jamaoto.2018.0652Search in Google Scholar PubMed

26. Lipitz S, Yinon Y, Malinger G, Yagel S, Levit L, Hoffman C, et al. Risk of cytomegalovirus-associated sequelae in relation to time of infection and findings on prenatal imaging. Ultrasound Obstet Gynecol 2013;41:508–14.10.1002/uog.12377Search in Google Scholar PubMed

27. Benoist G, Salomon LJ, Jacquemard F, Daffos F, Ville Y. The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. Br J Obstet Gynaecol 2008;115:823–9.10.1111/j.1471-0528.2008.01714.xSearch in Google Scholar PubMed

28. Farkas N, Hoffmann C, Ben-Sira L, Lev D, Schweiger A, Kidron D, et al. Does normal fetal brain ultrasound predict normal neurodevelopmental outcome in congenital cytomegalovirus infection? Prenat Diagn 2011;31:360–6.10.1002/pd.2694Search in Google Scholar PubMed

29. Birnbaum R, Ben-Sira L, Lerman-Sagie T, Malinger G. The use of fetal neurosonography and brain MRI in cases of cytomegalovirus infection during pregnancy: a retrospective analysis with outcome correlation. Prenat Diagn 2017;37:1335–42.10.1002/pd.5180Search in Google Scholar PubMed

30. Cannie MM, Devlieger R, Leyder M, Claus F, Leus A, De Catte L, et al. Congenital cytomegalovirus infection: contribution and best timing of prenatal MR imaging. Eur Radiol 2016;26:3760–9.10.1007/s00330-015-4187-0Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpm-2019-0331).


Received: 2019-09-06
Accepted: 2019-12-29
Published Online: 2020-02-06
Published in Print: 2020-03-26

©2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Corner of Academy
  3. Operative vaginal delivery: a review of four national guidelines
  4. Mini Review
  5. Drug exposure during pregnancy and fetal cardiac function – a systematic review
  6. Original Articles – Obstetrics
  7. Pregnancy outcomes among women with peptic ulcer disease
  8. The effect of placental elasticity on intraoperative bleeding in pregnant women with previous cesarean section
  9. Cellular immune responses in amniotic fluid of women with preterm prelabor rupture of membranes
  10. Prenatal findings, neonatal symptoms and neurodevelopmental outcome of congenital cytomegalovirus infection in a university hospital in Montreal, Quebec
  11. Maternal obesity influences the endocrine cord blood profile of their offspring
  12. Value of cervicovaginal fluid cytokines in prediction of fetal inflammatory response syndrome in pregnancies complicated with preterm premature rupture of membranes (pPROM)
  13. Reliability of strain elastography using in vivo compression in the assessment of the uterine cervix during pregnancy
  14. Original Articles – Fetus
  15. Comparison of strain and dyssynchrony measurements in fetal two-dimensional speckle tracking echocardiography using Philips and TomTec
  16. Quantitative measurements of celeration times and indexes in the ductus venosus spectral Doppler waveforms in normal fetuses
  17. Original Articles – Newborns
  18. Evaluation of cerebral oxygenation and perfusion in small for gestational age neonates and neurodevelopmental outcome at 24–36 months of age
  19. Measurement of inotropy and systemic oxygen delivery in term, low- and very-low-birth-weight neonates using the Ultrasonic Cardiac Output Monitor (USCOM)
  20. Short-term neurological improvement in neonates with hypoxic-ischemic encephalopathy predicts neurodevelopmental outcome at 18–24 months
Downloaded on 24.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2019-0331/html
Scroll to top button